RT Journal Article
SR Electronic
T1 Causal Mediation Analysis with Multiple Causally Ordered and Non-ordered Mediators based on Summarized Genetic Data
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.01.07.21249415
DO 10.1101/2021.01.07.21249415
A1 Hou, Lei
A1 Yu, Yuanyuan
A1 Sun, Xiaoru
A1 Liu, Xinhui
A1 Yu, Yifan
A1 Yan, Ran
A1 Li, Hongkai
A1 Xue, Fuzhong
YR 2021
UL http://medrxiv.org/content/early/2021/01/08/2021.01.07.21249415.abstract
AB Causal mediation analysis aims to investigate the mechanism linking an exposure and an outcome. Dealing with the impact of unobserved confounders among the exposure, mediator and outcome has always been an issue of great concern. Moreover, when multiple mediators exist, this causal pathway intertwines with other causal pathways, making it more difficult to estimate of path-specific effects (PSEs). In this article, we propose a method (PSE-MR) to identify and estimate PSEs of an exposure on an outcome through multiple causally ordered and non-ordered mediators using Mendelian Randomization, when there are unmeasured confounders among the exposure, mediators and outcome. Additionally, PSE-MR can be used when pleiotropy exists, and can be implemented using only summarized genetic data. We also conducted simulations to evaluate the finite sample performances of our proposed estimators in different scenarios. The results show that the causal estimates of PSEs are almost unbiased with good coverage and Type I error properties. We illustrate the utility of our method through a study of exploring the mediation effects of lipids in the causal pathways from body mass index to cardiovascular disease.Author summary A new method (PSE-MR) is proposed to identify and estimate PSEs of an exposure on an outcome through multiple causally ordered and non-ordered mediators using summarized genetic data, when there are unmeasured confounders among the exposure, mediators and outcome. Lipids play important roles in the causal pathways from body mass index to cardiovascular diseaseCompeting Interest StatementThe authors have declared no competing interest.Funding StatementFX was supported by the National Natural Science Foundation of China (Grant 81773547) and Shandong Provincial Key Research and Development project (2018CXGC1210). HL was supported by the National Natural Science Foundation of China (Grant 82003557).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval was not sought, because this study involved analysis of publicly available summary-level data from GWASs, and no individual-level data were used.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesGWAS summary data for BMI, Lipids and CVD are publicly available at https://portals.broadinstitute.org/collaboration/giant/index.php/GIANT_consortium_data_files, http://lipidgenetics.org/ and http://www.cardiogramplusc4d.org/, respectively. Code to implement the method and reproduce all simulations and analyses is available on Github (https://github.com/hhoulei/PSEMR).